Oritavancin for Treatment of Serious Cardiac Infections

NCT07550595 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Infective Endocarditis
Cardiac Device Infection
Gram-positive Bacterial Infections

Interventions

DRUG: Oritavancin
DRUG: Oritavancin

Sponsor

Kirby Institute